Haw Par Healthcare Ltd.

Form 483 issued September 27, 2024 · Singapore, Singapore

Inspection
Sep 23 – Sep 27, 2024
Observations
7
Pages
7
FEI number
3001432470

In short: On September 27, 2024, FDA issued a Form 483 with 7 observations to Haw Par Healthcare Ltd. in Singapore, Singapore (FEI 3001432470) after an inspection that ran Sep 23 – Sep 27, 2024. The investigators were Samantha E. Cleek and Tamil Arasu. Most observations concern quality system and materials; the most-cited regulation is 21 CFR 211.80 (general requirements).

At a glance

Observations span 4 systems, led by quality system.

Quality system2
Materials2
Laboratory controls1
Packaging & labeling1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

  2. 02

    Each batch of drug product required to be free of objectionable microorganisms is not tested…

  3. 03

    The drug product is not identified with a lot or control number that permits the determination…

  4. 04

    Time limits are not established when appropriate for the completion of each production phase to assure…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Haw Par Healthcare Ltd.?

FDA listed 7 observations on this Form 483, mostly about quality system, materials and laboratory controls. The most-cited regulation is 21 CFR 211.80 (general requirements). The opening words of each observation are shown on this page.

Who inspected Haw Par Healthcare Ltd.?

Samantha E. Cleek and Tamil Arasu are named on this Form 483, for the inspection of Sep 23 – Sep 27, 2024. Each investigator has a profile showing what they cite most.

When was Haw Par Healthcare Ltd. inspected by FDA?

The inspection ran Sep 23 – Sep 27, 2024, and the Form 483 is dated September 27, 2024.

How do I get the full Form 483 for Haw Par Healthcare Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free